Viewpoint: Pathway-Sensitive Eligibility for Biologic Therapy in COPD: The Role of Primary Care, Phenotyping, and Eosinophil-Guided Management

Respiratory Medicine · Published 2026-08-01 · DOI 10.1016/j.rmed.2026.109083

Authors (3)

Konstantinos Bartziokas, Constantinos Glynos, Andriana I. Papaioannou

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bartziokas, K., Glynos, C., Papaioannou, A. (2026). Viewpoint: Pathway-Sensitive Eligibility for Biologic Therapy in COPD: The Role of Primary Care, Phenotyping, and Eosinophil-Guided Management. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109083

Related articles

• Immunosuppressive medication patterns in rheumatoid arthritis–associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic health record study · Respiratory Medicine · 2026 · Same journal
• Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease · Respiratory Medicine · 2026 · Same journal
• Adults with congenital lung malformations: A descriptive analysis of an underexplored population · Respiratory Medicine · 2026 · Same journal
• Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes · Respiratory Medicine · 2026 · Same journal
• Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma · Respiratory Medicine · 2026 · Same journal
• Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience · Respiratory Medicine · 2026 · Same journal
• Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients · Respiratory Medicine · 2026 · Same journal
• Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management · Respiratory Medicine · 2026 · Same journal
• Oxidative Stress–Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications · Respiratory Medicine · 2026 · Same journal
• Smoking cessation and depression risk in newly diagnosed COPD patients: A nationwide cohort study · Respiratory Medicine · 2026 · Same journal